MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $559 | +31.5% | 12,823 | +9.0% | 0.04% | +26.5% |
| Q2 2023 | $425 | +16.1% | 11,760 | +19.4% | 0.03% | +25.9% |
| Q1 2023 | $366 | -19.7% | 9,847 | -2.1% | 0.03% | -28.9% |
| Q4 2022 | $456 | -99.9% | 10,055 | +78.9% | 0.04% | +2.7% |
| Q3 2022 | $393,000 | -21.1% | 5,620 | -24.2% | 0.04% | -17.8% |
| Q2 2022 | $498,000 | +82.4% | 7,413 | +123.2% | 0.04% | +400.0% |
| Q1 2022 | $273,000 | – | 3,321 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |